The Control of Hyperglycaemia In Paediatric intensive care (The CHIP Trial). - The CHIP Trial
- Conditions
- hyperglycaemiaMedDRA version: 9.1Level: LLTClassification code 10020635Term: Hyperglycaemia
- Registration Number
- EUCTR2006-005715-10-GB
- Lead Sponsor
- Royal Brompton & Harefield NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 1500
Children from birth to <16 years who are undergoing intensive care treatment with an arterial line in-situ and receiving both mechanical ventilation and vasoactive support drugs following injury, major surgery or in association with critical illness in whom it is anticipated such treatment will be required to continue for at least 12 hours.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Children born pre-term and who are < 36 weeks corrected gestation
Children with diabetes mellitus
Children with an established or suspected diagnosis of an inborn error of metabolism
Children for whom treatment withdrawal or limitation of intensive care treatment is being considered
Children who have been in a PICU for more than 5 days in succession
Children admitted to a PICU who have already participated in the CHIP study during a previous PICU admission.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method